Literature DB >> 12943180

Effects of Qigong on blood pressure, blood pressure determinants and ventilatory function in middle-aged patients with essential hypertension.

Myung Suk Lee1, Myeong Soo Lee, Euy-Soon Choi, Hun-Taeg Chung.   

Abstract

This study was designed to measure changes in blood pressure (BP), urinary catecholamines and ventilatory functions of patients with mild essential hypertension after 10 weeks of Qigong (Shuxinpingxuegong). Fifty-eight patients volunteered to participate in this study and were randomly divided into either a Qigong group (n = 29), or a control group (n = 29). Systolic blood pressure and diastolic blood pressure decreased significantly in the Qigong group such that both became significantly lower after 10 weeks in the Qigong than in the control group. Also, there was a significant reduction of norepinephrine, metanephrine and epinephrine compared to baseline values in the Qigong group. The ventilatory functions, forced vital capacity and forced expiratory volume per sec, were increased in the Qigong group but not the control. These results suggest that Qigong may stabilize the sympathetic nervous system is effective in modulating levels of urinary catecholamines and BP positively, and in improving ventilatory functions in mildly hypertensive middle-aged patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943180     DOI: 10.1142/S0192415X03001120

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  23 in total

Review 1.  A comprehensive review of health benefits of qigong and tai chi.

Authors:  Roger Jahnke; Linda Larkey; Carol Rogers; Jennifer Etnier; Fang Lin
Journal:  Am J Health Promot       Date:  2010 Jul-Aug

Review 2.  Alternative Therapies in the Treatment of Atrial Fibrillation.

Authors:  Federico Lombardi; Sebastiano Belletti; Alberto Lomuscio
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 3.  Menopause, the metabolic syndrome, and mind-body therapies.

Authors:  Kim E Innes; Terry Kit Selfe; Ann Gill Taylor
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

4.  Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Bo Feng; Jizheng Ma; Xinliang Du; Pengqian Wang; Fuyong Chu; Jun Li; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

5.  Effects of qigong on depression: a systemic review.

Authors:  Byeongsang Oh; Sun Mi Choi; Aya Inamori; David Rosenthal; Albert Yeung
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-04       Impact factor: 2.629

6.  Evidence-based chinese medicine for hypertension.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

7.  The treatment of depressed chinese americans using qigong in a health care setting: a pilot study.

Authors:  Albert Yeung; Lauren E Slipp; Jolene Jacquart; Maurizio Fava; John W Denninger; Herbert Benson; Gregory L Fricchione
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-16       Impact factor: 2.629

Review 8.  Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science.

Authors:  Xingjiang Xiong; Xiaochen Yang; Yongmei Liu; Yun Zhang; Pengqian Wang; Jie Wang
Journal:  Hypertens Res       Date:  2013-04-04       Impact factor: 3.872

9.  The effects of qigong on anxiety, depression, and psychological well-being: a systematic review and meta-analysis.

Authors:  Fang Wang; Jenny K M Man; Eun-Kyoung Othelia Lee; Taixiang Wu; Herbert Benson; Gregory L Fricchione; Weidong Wang; Albert Yeung
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-14       Impact factor: 2.629

10.  Developing and testing the effectiveness of a novel health qigong for frail elders in Hong Kong: a preliminary study.

Authors:  Hector W H Tsang; Janet L C Lee; Doreen W H Au; Karen K W Wong; K W Lai
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.